Login / Signup

Effect of Avenciguat on Albuminuria in Patients with CKD: Two Randomized Placebo-Controlled Trials.

Hiddo J Lambers HeerspinkDavid CherneyAbdul Halim Abdul GaforJose Luis Gorriz TeruelPablo E PergolaSydney Chi-Wai TangMarc DeschHristo IlievZhichao SunDominik SteublMasaomi Nangaku
Published in: Journal of the American Society of Nephrology : JASN (2024)
Avenciguat lowered albuminuria, and was well tolerated in patients with CKD.
Keyphrases
  • placebo controlled
  • double blind
  • chronic kidney disease
  • phase iii
  • phase ii
  • clinical trial
  • study protocol
  • phase ii study
  • open label
  • randomized controlled trial
  • squamous cell carcinoma
  • radiation therapy